In fiscal year 2023, Congress passed a consolidated appropriations act allocating $7.104 billion to NCI. NCI was also appropriated $216 million in fiscal year 2023 as a result of the 21st Century Cures Act. After permissive transfers, $7.231 billion was available to NCI to obligate.
In addition to the appropriated amount for the fiscal year, NCI entered into inter- and intra-agency agreements with other federal agencies and NIH Institutes and Centers (ICs). These agreements often provide reimbursements for materials, supplies, equipment, work, or services to assist other agencies and ICs accomplish their missions.
| Actual Obligations Resulting from Appropriated Funds | FY23 Amount |
|---|---|
| FY23 Appropriation | $7,104,159,000 |
| FY23 Cancer Moonshot Appropriation | $216,000,000 |
| Secretary's Transfer | $0 |
| Transfer to NIH Office of AIDS Research | -$2,918,000 |
| Lapse | -$234,418 |
| Cancer Moonshot Carryover | -$129,405,086 |
| Actual Obligations Subtotal | $7,187,601,496 |
| Reimbursable Obligations | $43,693,202 |
| Total NCI Obligations | $7,231,294,698 |
Includes FY23 Cures Moonshot℠ funding and excludes fiscal years 2022 through 2017 Cures Moonshot carryover obligations.